| View |
|
DRP-1225-06
|
Cefalexin (as Monohydrate)
|
Ceflin
|
100 mg/mL
|
Powder for Suspension
|
Antibacterial (Cephalosporins)
|
Lifesquare Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
04 September 2024
|
19 January 2030
|
| View |
|
DRP-12263-04
|
Ursodeoxycholic Acid
|
None
|
500 mg
|
Film-Coated Tablet
|
Bile Acid and Derivative
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
04 September 2024
|
06 July 2027
|
| View |
|
DRP-12292-05
|
Febuxostat
|
Febulitt
|
40 mg
|
Film-Coated Tablet
|
Antigout
|
Cooper Pharma Limited
|
India
|
CLIDP Conversion
|
20 August 2024
|
12 July 2027
|
| View |
|
DRP-12302-01
|
Pregabalin + Mecobalamin
|
Preva M
|
75 mg/750 mcg
|
Capsule
|
Antiepileptic/Vitamin (Cyanocobalamin analogue combination)
|
Tirupati Medicare Limited
|
India
|
CLIDP Conversion
|
04 September 2024
|
23 May 2026
|
| View |
|
DRP-12333-05
|
Diosmin + Hesperidin
|
Dioxel
|
900 mg/ 100 mg
|
Tablet
|
Vasoprotective
|
Saga Lifesciences Limited
|
India
|
CLIDP Conversion
|
08 September 2024
|
20 July 2027
|
| View |
|
DRP-12412-11
|
Losartan Potassium
|
Ysartan
|
50 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Antagonist
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
20 August 2024
|
03 August 2025
|
| View |
|
DRP-12671-05
|
Ketorolac Trometamol
|
Pentolac
|
30 mg/mL
|
Solution for Injection (I.M./I. V.)
|
Non-Steroidal Anti-inflammatory and Anti-rheumatic Product (Acetic Acid Derivative)
|
Scott-Edil Pharmacia Limited
|
India
|
CLIDP Conversion
|
23 August 2024
|
21 September 2027
|
| View |
|
DRP-12737-08
|
Telmisartan + Amlodipine (as besilate)
|
Cardialta
|
80 mg / 5 mg
|
Tablet
|
Angiotensin II Receptor Blocker/ Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
25 August 2024
|
30 September 2027
|
| View |
|
DRP-12738-10
|
Telmisartan + Amlodipine (as besilate)
|
Cardialta
|
40 mg/5 mg
|
Tablet
|
Angiotensin II Receptor Blocker/ Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
04 September 2024
|
30 September 2027
|
| View |
|
DRP-12791-03
|
Amlodipine (as Besilate) + Hydrochlorothiazide
|
Amlomel Plus
|
10 mg/12.5 mg
|
Tablet
|
Calcium channel blocker and diuretic
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
04 September 2024
|
28 October 2027
|
| View |
|
DRP-13096-04
|
Ketoanalogues + Essential Amino Acids
|
Nephzor
|
630 mg
|
Film-Coated Tablet
|
Renal Nutrition Therapy
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
04 September 2024
|
01 December 2027
|
| View |
|
DRP-13149-03
|
Ascorbic Acid + Zinc
|
None
|
500 mg (equivalent to 562.43 mg Sodium Ascorbate) / 10 mg (27.5 mg Zinc Sulfate Monohydrate)
|
Capsule
|
Vitamin and Mineral
|
St. Martin Pharm Lab Co.,
|
Philippines
|
CLIDP Conversion
|
04 September 2024
|
12 December 2027
|
| View |
|
DRP-13558-04
|
Lapatinib (as ditosylate monohydrate)
|
Brestin
|
250 mg
|
Film-Coated Tablet
|
Antineoplastic Agent
|
BDR Pharmaceuticals International Pvt. Ltd.–Oncology Unit
|
India
|
CLIDP Conversion
|
04 September 2024
|
09 March 2028
|
| View |
|
DRP-13665-02
|
Cefixime (as trihydrate)
|
Unofix
|
200 mg
|
Dispersible Tablet (Trusil Strawberry Flavor)
|
Antibacterial (Cephalosporin)
|
lnnova Captab Pvt. Ltd.
|
India
|
CLIDP Conversion
|
25 August 2024
|
23 March 2028
|
| View |
|
DRP-13685-03
|
Ceftriaxone (as sodium)
|
Gotaxone
|
1 g Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Antibacterial (Cephalosporin)
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
08 September 2024
|
28 March 2028
|
| View |
|
DRP-13686-07
|
Losartan Potassium
|
Zelosart-100
|
100 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
04 September 2024
|
28 March 2028
|
| View |
|
DRP-13687-09
|
Losartan Potassium
|
L-Zerprime
|
50 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
08 September 2024
|
28 March 2028
|
| View |
|
DRP-13862-02
|
Paracetamol
|
Parazel
|
150 mg/mL
|
Solution for Injection (IM/IV)
|
Analgesic/Antipyretic
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
04 September 2024
|
04 May 2028
|
| View |
|
DRP-13973-01
|
Atorvastatin (as calcium)
|
Avarix 20
|
20 mg
|
Film-Coated Tablet
|
Lipid Modifying Agent (HMG CoA reductase inhibitor)
|
Healer’s Lab (Unit II)
|
India
|
CLIDP Conversion
|
24 August 2024
|
26 May 2028
|
| View |
|
DRP-13986-02
|
Apixaban
|
Verapix
|
5 mg
|
Film-Coated Tablet
|
Antithrombotic Agent (Direct factor Xa inhibitor)
|
Intas Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
04 September 2024
|
31 May 2028
|